SCHEMBL5196368

SCHEMBL5196368

COC(=O)[C@@H](NC(=O)OCc1ccccc1)[C@H](C)OCc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.58
CTSL P07711 3/20 0.55
CTSS P25774 3/20 0.55
ATM Q13315 1/20 0.53
CTSB P07858 2/20 0.53
MMP9 P14780 2/20 0.52
MMP8 P22894 2/20 0.52
ALDH1A1 P00352 1/20 0.52
ALOX15 P16050 1/20 0.52
CTSK P43235 3/20 0.52
KYNU Q16719 1/20 0.51
MEN1 O00255 2/20 0.51
LMNA P02545 2/20 0.51
KMT2A Q03164 2/20 0.51
CTRB1 P17538 2/20 0.50
ELANE P08246 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
TSHR P16473 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11573515 0.90 CTSL (0.56) TRPM8CTSLCTSSATMCTSB
SCHEMBL1132567 0.90 CTSL (0.56) TRPM8CTSLCTSSATMCTSB
SCHEMBL1132569 0.90 CTSL (0.56) TRPM8CTSLCTSSATMCTSB
SCHEMBL10421483 0.90 CTSL (0.56) TRPM8CTSLCTSSATMCTSB
SCHEMBL5192939 0.90 TRPM8 (0.60) TRPM8CTSLCTSSATMCTSB
SCHEMBL15879567 0.90 TRPM8 (0.60) TRPM8CTSLCTSSATMCTSB
SCHEMBL5195885 0.88 TRPM8 (0.57) TRPM8CTSLCTSSATMCTSB
SCHEMBL12028840 0.88 CTSL (0.54) TRPM8CTSLCTSSATMCTSB
SCHEMBL30251969 0.87 TRPM8 (0.52) TRPM8CTSLCTSSATMCTSB
SCHEMBL18078251 0.87 TRPM8 (0.52) TRPM8CTSLCTSSATMCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249670-A1 Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof SMITHKLINE BEECHAM CORPORATION (US) 2007-10-25 US disclosed
EP-1812383-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF Smithkline Beecham Corporation (US) 2007-08-01 EP disclosed
WO-2006052722-A1 GLYCOGEN PHOSPHORYLASE INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF SMITHKLINE BEECHAM CORPORATION (US) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249670-A1 Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof PYGM, PYGL, GYS1 TRPM8 4399/4885CTSL 2073/4885CTSS 1634/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.